Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TBC1D7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RFWD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR1D5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM111A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUCLA2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARL8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLNK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC2A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1S3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3D21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS26A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRCAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on